4-aminoquinoline has been researched along with piperidines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lupa, MT; Tabti, N; Thesleff, S; Vyskocil, F; Yu, SP | 1 |
| Esmaeili, S; Fassihi, A; Fayyazi, N; Ghasemi, JB; Saghaie, L; Taheri, S | 1 |
2 other study(ies) available for 4-aminoquinoline and piperidines
| Article | Year |
|---|---|
The nature and origin of calcium-insensitive miniature end-plate potentials at rodent neuromuscular junctions.
Topics: Acetylcholine; Action Potentials; Aminoquinolines; Animals; Botulinum Toxins; Calcium; Hemicholinium 3; In Vitro Techniques; Mice; Motor Endplate; Neuromuscular Depolarizing Agents; Neuromuscular Junction; Phencyclidine; Piperidines; Rats; Rats, Inbred Strains; Temperature; Time Factors | 1986 |
Molecular dynamics simulation and 3D-pharmacophore analysis of new quinoline-based analogues with dual potential against EGFR and VEGFR-2.
Topics: A549 Cells; Aminoquinolines; Antineoplastic Agents; Binding Sites; Cell Line, Tumor; ErbB Receptors; Erlotinib Hydrochloride; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Piperidines; Protein Conformation; Quinazolines; Quinolines; Sorafenib; Vascular Endothelial Growth Factor Receptor-2 | 2020 |